Cargando…
Overcoming Obstacles to Targeting Muscarinic Receptor Signaling in Colorectal Cancer
Despite great advances in our understanding of the pathobiology of colorectal cancer and the genetic and environmental factors that mitigate its onset and progression, a paucity of effective treatments persists. The five-year survival for advanced, stage IV disease remains substantially less than 20...
Autores principales: | Ali, Osman, Tolaymat, Mazen, Hu, Shien, Xie, Guofeng, Raufman, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828259/ https://www.ncbi.nlm.nih.gov/pubmed/33450835 http://dx.doi.org/10.3390/ijms22020716 |
Ejemplares similares
-
The Role of M3 Muscarinic Receptor Ligand-Induced Kinase Signaling in Colon Cancer Progression
por: Tolaymat, Mazen, et al.
Publicado: (2019) -
Potential Role for Combined Subtype-Selective Targeting of M(1) and M(3) Muscarinic Receptors in Gastrointestinal and Liver Diseases
por: Tolaymat, Mazen, et al.
Publicado: (2021) -
Muscarinic receptor signaling and colon cancer progression
por: Xie, Guofeng, et al.
Publicado: (2016) -
Differential Actions of Muscarinic Receptor Subtypes in Gastric, Pancreatic, and Colon Cancer
por: Schledwitz, Alyssa, et al.
Publicado: (2021) -
Muscarinic Receptor Signaling in Colon Cancer
por: von Rosenvinge, Erik C., et al.
Publicado: (2011)